Market Cap 36.37M
Revenue (ttm) 7.57M
Net Income (ttm) -76.58M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,011.62%
Debt to Equity Ratio -2.13
Volume 108,800
Avg Vol 343,734
Day's Range N/A - N/A
Shares Out 9.45M
Stochastic %K 15%
Beta 1.71
Analysts Sell
Price Target $15.00

Company Profile

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and sale of medications for the treatment of skin diseases in the United States. The company's product pipeline includes YCANTH (VP-102), which is in phase III clinical trial for the treatment of common warts; and has completed phase II clinical trial for treating external genital warts, as well as for molluscum contagiosum. It also develops VP-315, an oncolytic peptide-based injectable therapy that is i...

Industry: Biotechnology
Sector: Healthcare
Phone: 484 453 3300
Address:
44 West Gay Street, Suite 400, West Chester, United States
glorrel
glorrel Oct. 27 at 8:16 PM
$VRCA added some today
0 · Reply
BioCapitalist99
BioCapitalist99 Oct. 27 at 4:40 PM
$VRCA not in the best shape, but things could turn around within 6m; good play for the medium term imho
1 · Reply
Stockseeking
Stockseeking Oct. 27 at 12:28 PM
$VRCA Q3 revenue including 10 million milestone payment from approval in Japan will be around 15 million. A market cap of only 36 million is undervalued
0 · Reply
zijad
zijad Oct. 25 at 8:13 AM
$VRCA very strong hold here. I’m waiting for much more
0 · Reply
Stockseeking
Stockseeking Oct. 24 at 12:29 PM
$VRCA Q3 rev will include 10 m from Torii milestone payment. Ycanth rev should be around 5.5 m.
0 · Reply
Stockseeking
Stockseeking Oct. 23 at 11:44 AM
$VRCA Q3 in 2 weeks to show increased YCANTH rev
0 · Reply
Bbboston
Bbboston Oct. 23 at 11:15 AM
$VRCA I originally bought because Perceptive Advisors bought. But then they sold (looks like at loss) and moved out. Didn’t like it but still holding. Manning still holding though. So we will see. I think ultimately, the Japanese partner ought to buy out this company, with such small MC, it may be better than paying royalties.
0 · Reply
Stockseeking
Stockseeking Oct. 23 at 11:09 AM
$VRCA YCANTH alone is worth the market cap of only around 37 m.
1 · Reply
Whales22
Whales22 Oct. 23 at 6:10 AM
How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI $SMLR $DCTH $NEXT $VRCA Watchlist>
0 · Reply
glorrel
glorrel Oct. 22 at 3:02 PM
$VRCA added
0 · Reply
Latest News on VRCA
Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results

May 13, 2025, 4:05 PM EDT - 5 months ago

Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results


Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D.

Mar 26, 2025, 7:00 AM EDT - 7 months ago

Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D.


Verrica Announces Pricing of $42.0 Million Public Offering

Nov 21, 2024, 7:30 AM EST - 1 year ago

Verrica Announces Pricing of $42.0 Million Public Offering


Verrica Announces Proposed Public Offering

Nov 20, 2024, 4:05 PM EST - 1 year ago

Verrica Announces Proposed Public Offering


glorrel
glorrel Oct. 27 at 8:16 PM
$VRCA added some today
0 · Reply
BioCapitalist99
BioCapitalist99 Oct. 27 at 4:40 PM
$VRCA not in the best shape, but things could turn around within 6m; good play for the medium term imho
1 · Reply
Stockseeking
Stockseeking Oct. 27 at 12:28 PM
$VRCA Q3 revenue including 10 million milestone payment from approval in Japan will be around 15 million. A market cap of only 36 million is undervalued
0 · Reply
zijad
zijad Oct. 25 at 8:13 AM
$VRCA very strong hold here. I’m waiting for much more
0 · Reply
Stockseeking
Stockseeking Oct. 24 at 12:29 PM
$VRCA Q3 rev will include 10 m from Torii milestone payment. Ycanth rev should be around 5.5 m.
0 · Reply
Stockseeking
Stockseeking Oct. 23 at 11:44 AM
$VRCA Q3 in 2 weeks to show increased YCANTH rev
0 · Reply
Bbboston
Bbboston Oct. 23 at 11:15 AM
$VRCA I originally bought because Perceptive Advisors bought. But then they sold (looks like at loss) and moved out. Didn’t like it but still holding. Manning still holding though. So we will see. I think ultimately, the Japanese partner ought to buy out this company, with such small MC, it may be better than paying royalties.
0 · Reply
Stockseeking
Stockseeking Oct. 23 at 11:09 AM
$VRCA YCANTH alone is worth the market cap of only around 37 m.
1 · Reply
Whales22
Whales22 Oct. 23 at 6:10 AM
How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI $SMLR $DCTH $NEXT $VRCA Watchlist>
0 · Reply
glorrel
glorrel Oct. 22 at 3:02 PM
$VRCA added
0 · Reply
BioCapitalist99
BioCapitalist99 Oct. 21 at 11:39 PM
$VRCA Verrica Pharmaceuticals is a classic example of a company whose lingering past overshadows its present transformation. Years of regulatory setbacks and delayed commercialization have weighed heavily on the share price, but in my view, we’ve reached the bottom. Today, the narrative is shifting. New management has stabilized execution and is now delivering tangible growth, as evidenced by accelerating YCANTH sales and expanding international partnerships. The company has moved beyond the uncertainty that once defined it and is entering a phase of measurable, sustainable performance. What makes the story even more compelling is Verrica’s pipeline potential. Their next clinical candidate, targeting basal cell and squamous cell carcinoma, is progressing steadily and could unlock significant additional value if early data trends hold. 38m market cap = good opportunity IMHO. Good luck
0 · Reply
glorrel
glorrel Oct. 21 at 9:22 PM
0 · Reply
BioCapitalist99
BioCapitalist99 Oct. 21 at 8:01 PM
0 · Reply
Stmkr
Stmkr Oct. 21 at 7:41 PM
$VRCA Why do they still work on VP-315? Any advantage over imiquimod?
0 · Reply
FetchDog
FetchDog Oct. 21 at 2:03 PM
$VRCA Starter position at $3.93. Sales will grow and finances are "manageable".
0 · Reply
nUme22
nUme22 Oct. 21 at 1:57 PM
$VRCA Dilution and then RS ?
1 · Reply
doodledo77
doodledo77 Oct. 21 at 9:23 AM
$VRCA seeing a decent bounce. NEWS was good but shorts went too far watching this morning 👀👀👀👀😉
0 · Reply
YouVSYou
YouVSYou Oct. 20 at 10:20 PM
$VRCA juicy dip
0 · Reply
MaksD
MaksD Oct. 20 at 9:49 PM
$VRCA bought 6 days ago at 3.98$ sold today @ $5.49 couldn't fix max gain sold on the way down. Now bought again at 3.82
0 · Reply
JancoFrames
JancoFrames Oct. 20 at 8:42 PM
$VRCA buying all I can here. More good news for YCANTH and VP-315 for skin cancer results at conference early November. This will be $8+ by EOY
1 · Reply
jdnyc
jdnyc Oct. 20 at 8:36 PM
$VRCA Today’s after hours activity proves that this has to be a very shady investment. Someone is making a lot of money off the stock, but not me because I’m a victim of their stock splitting scheme last summer.
0 · Reply
premarketmaker
premarketmaker Oct. 20 at 8:34 PM
$VRCA ready for approval - first and only to treat molluscum - a common skin pediatric skin rash - one dose!/6 million per year
0 · Reply